114 related articles for article (PubMed ID: 3715193)
1. Sorbitol clearance: a parameter reflecting liver plasma flow in the rat.
Molino G; Avagnina P; Cavanna A; Ballarè M; Torchio M; Bona B; Belforte G
Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):119-32. PubMed ID: 3715193
[TBL] [Abstract][Full Text] [Related]
2. Pirenzepine does not impair liver blood flow in the rat.
Molino G; Avagnina P; Torchio M; Garrone M; Fronda GR
Int J Tissue React; 1983; 5(3):297-9. PubMed ID: 6689166
[TBL] [Abstract][Full Text] [Related]
3. Sorbitol as a test substance for measurement of liver plasma flow in humans.
Keiding S; Engsted E; Ott P
Hepatology; 1998 Jul; 28(1):50-6. PubMed ID: 9657096
[TBL] [Abstract][Full Text] [Related]
4. [Evaluating liver functional reserve by combining D-sorbitol with indocyanine green measurement].
Gao WT; Li YM; Ji H; Yang WB
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):350-3. PubMed ID: 12837214
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
6. Hepatic clearance of D-sorbitol. Noninvasive test for evaluating functional liver plasma flow.
Molino G; Cavanna A; Avagnina P; Ballaré M; Torchio M
Dig Dis Sci; 1987 Jul; 32(7):753-8. PubMed ID: 3595388
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive functional liver blood flow measurement: comparison between bolus dose and steady-state clearance of sorbitol in a small-rodent model.
van der Hoven B; van Pelt H; Swart EL; Bonthuis F; Tilanus HW; Bakker J; Gommers D
Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G177-81. PubMed ID: 19940028
[TBL] [Abstract][Full Text] [Related]
8. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats.
Iwamoto K; Watanabe J; Araki K; Satoh M; Deguchi N
J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680
[TBL] [Abstract][Full Text] [Related]
9. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.
Callaghan R; Desmond PV; Paull P; Mashford ML
Hepatology; 1993 Jul; 18(1):54-60. PubMed ID: 8325621
[TBL] [Abstract][Full Text] [Related]
10. First-order clearance of plasma galactose: the effect of liver disease.
Henderson JM; Kutner MH; Bain RP
Gastroenterology; 1982 Nov; 83(5):1090-6. PubMed ID: 7117792
[TBL] [Abstract][Full Text] [Related]
11. D-sorbitol plasma disappearance rate: an index to evaluate changes in liver circulation.
Ballarè M; Avagnina P; Torchio M; Cavanna A; Aurucci PE; Niro AG; Molino G
Ric Clin Lab; 1988; 18(4):305-11. PubMed ID: 3247561
[TBL] [Abstract][Full Text] [Related]
12. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
Leveille-Webster CR; Rogers J; Arias IM
Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
[TBL] [Abstract][Full Text] [Related]
13. Hepatic plasma flow estimated according to Fick's principle in patients with hepatic encephalopathy: evaluation of indocyanine green and D-sorbitol as test substances.
Clemmesen JO; Tygstrup N; Ott P
Hepatology; 1998 Mar; 27(3):666-73. PubMed ID: 9500692
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
[TBL] [Abstract][Full Text] [Related]
15. Hepatic clearance and biliary secretion of protoporphyrin in the isolated, in situ-perfused rat liver.
Avner DL; Berenson MM
J Lab Clin Med; 1982 Jun; 99(6):885-94. PubMed ID: 7077129
[TBL] [Abstract][Full Text] [Related]
16. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
Imawaka H; Sugiyama Y
J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation on blood clearance and hepatic uptake of 99mTc-GSA in rats with blood flow conversion].
Ohno K
Hokkaido Igaku Zasshi; 1997 May; 72(3):297-307. PubMed ID: 9226469
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
19. Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance.
Piekoszewski W; Chow FS; Jusko WJ
Drug Metab Dispos; 1993; 21(4):690-8. PubMed ID: 7690698
[TBL] [Abstract][Full Text] [Related]
20. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion.
Chow FS; Piekoszewski W; Jusko WJ
Drug Metab Dispos; 1997 May; 25(5):610-6. PubMed ID: 9152601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
